
Celldex Therapeutics, Inc. (CLDX)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
33.29 - Open
33.15 - Bid 29.04 x 100
- Ask 38.87 x 100
- Day's Range
33.15 - 34.50 - 52 Week Range
17.85 - 35.79 - Volume
201,338 - Avg. Volume
1,037,542 - Market Cap (intraday)
2.683B - Beta (5Y Monthly) 1.20
- PE Ratio (TTM)
-- - EPS (TTM)
-3.90 - Earnings Date (est.) May 7, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
57.00
Recent News: CLDX
View MorePerformance Overview: CLDX
Trailing total returns as of 4/27/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends: CLDX
View MoreAnalyst Insights: CLDX
View MoreStatistics: CLDX
View MoreValuation Measures
-
Market Cap
2.61B
-
Enterprise Value
2.10B
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
1.43k
-
Price/Book (mrq)
4.95
-
Enterprise Value/Revenue
1.36k
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-26.12%
-
Return on Equity (ttm)
-40.62%
-
Revenue (ttm)
1.54M
-
Net Income Avi to Common (ttm)
-258.76M
-
Diluted EPS (ttm)
-3.90
Balance Sheet and Cash Flow
-
Total Cash (mrq)
518.57M
-
Total Debt/Equity (mrq)
0.44%
-
Levered Free Cash Flow (ttm)
-125.54M
Compare To: CLDX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.



